Class II
Ongoing
Tizanidine Tablets USP, 4 mg, 1000-Count bottle, Rx Only, Manufactured by Dr. Reddy's Laboratories Limited Srikakulam - 532 409 India. NDC 55111-180-10
This recall is currently active, issued July 26, 2023. It was issued by Dr Reddy'S Laboratories Limited.
- Company
- Dr Reddy'S Laboratories Limited
- Recall Initiated
- June 21, 2023
- Posted
- July 26, 2023
- Recall Number
- D-0923-2023
- Quantity
- 17,548 1000-countbottles
- Firm Location
- Ranasthalam Mandal, Srikakulam, India
- Official Source
- View on FDA website ↗
Reason for Recall
Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Distribution
Nationwide in the USA
Lot / Code Info
Lot: T2100585, T2100586, T2100587, Exp 12/2023
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026